Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis - A double-blind, randomized, phase-2 clinical trial

Journal of Ocular Pharmacology and Therapeutics

Volumn 21, Issue 2, 2005, Pages 157-165

  Teuchner, Barbara ^a   Nagl, Markus ^a   Schidlbauer, Axel ^a   Ishiko, Hiroaki ^b   Dragosits, Ernst ^a   Ulmer, Hanno ^a   Aoki, Koki ^c   Ohno, Shigeaki ^d   Mizuki, Nobuhisa ^c   Gottardi, Waldemar ^a   Larcher, Clara ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b LSI MEDIENCE CORPORATION   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; GENTAMICIN; GENTAX; N CHLOROTAURINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ADENOVIRUS; ADENOVIRUS 19; ADENOVIRUS 3; ADENOVIRUS 37; ADENOVIRUS 4; ADENOVIRUS 8; ADOLESCENT; ADULT; AGED; AQUEOUS SOLUTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ENTEROVIRUS; EPIDEMIC; FEMALE; HUMAN; KERATOCONJUNCTIVITIS; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; STAPHYLOCOCCUS;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CHILD; DISEASE OUTBREAKS; DOUBLE-BLIND METHOD; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; GENTAMICINS; HUMANS; KERATOCONJUNCTIVITIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TAURINE;

EID: 20244387976     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2005.21.157     Document Type: Article

References (25)

1. Gordon, Y.J., Aoki, K., and Kinchington, P.R. Adenovirus keratoconjunctivitis. In: Pepose, J.S., Holland, G.N., and Wilhelmys, K., eds. Ocular Infection and Immunity. St. Louis: Mosby, 877-894, 1996.
2. Kinchington, P.R., Turse, S.E., Kowalski, R.P., et al. Use of polymerase chain amplification reaction for the detection of adenoviruses in ocular swab specimens. Invest. Ophthalmol. Vis. Sci. 35:4126-4134, 1994.
3. Gottsch, J.D., Froggatt, J.W. III, Smith, D.M., et al. Prevention and control of epidemic keratoconjunctivitis in a teaching eye institute. Ophthalmic Epidemiol. 6:29-39, 1999.
4. Ward, J.B., Siojo, L.G., and Waller, S.G. A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis. Cornea 12:216-221, 1993.
5. Hutter, H. Epidemic keratoconjunctivitis: Treatment results during an epidemic. Klin. Monatsbl. Augenheilkd. 197:214-217, 1990.
6. Gordon, Y.J., Araullo-Cruz, T., and Romanowski, E.G. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication. Arch. Ophthalmol. 116:900-905, 1998.
7. Kaufman, H.E. Treatment of viral diseases of the cornea and external eye. Prog. Retin. Eye Res. 19:69-85, 2000.
8. Schuhman, G., and Vidic, B. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis. J. Hosp. Infect. 6(Suppl A):173-175, 1985.
9. Grisham, M.B., Jefferson, M.M., Melton, D.F., et al. Chlorination of endogenous amines by isolated neutrophils. J. Biol. Chem. 259:10404-10413, 1984.
10. Gottardi, W., and Nagl, M. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch. Pharm. (Weinheim) 335:411-421, 2002.
11. Nagl, M., Lass-Floerl, C., Neher, A., et al. Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J. Antimicrob. Chemother. 47:871-874, 2001.
12. Nagl, M., Hengster, P., Semenitz, E., et al. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J. Antimicrob. Chemother. 43:805-809,1999.
13. Nagl, M., and Gottardi, W. Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg. Med. 21:597-605, 1996.
14. Nagl, M., Larcher, C., and Gottardi, W. Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res. 38:25-30, 1998.
15. Romanowski, E.G., Yates, K.A., Teuchner, B., et al. In vitro evaluation of the new antimicrobial agent N-chlorotaurine (NCT) against ocular isolates of adenovirus. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). Fort Lauderdale, Florida, May 5-10, 2002.
16. Koyama, I., Nakamori, K., Nagahama, T., et al. The reactivity of taurine with hypochlorous acid and its application for eye drops. Adv. Exp. Med. Biol. 403:9-18, 1996.
17. Nagl, M., Miller, B., Daxecker, F., et al. Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye-a phase I clinical study. J. Ocul. Pharmacol. Ther. 14:283-290, 1998.
18. Nagl, M., Teuchner, B., Pöttinger, E., et al. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis-a phase II pilot study. Ophthalmologica 214:111-114, 2000.
19. Rotbart, H.A., Sawyer, M.H., Fast, S., et al. Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay. J. Clin. Microbiol. 32:2590-2592, 1994.
20. Saitoh-Inagawa, W., Oshima, A., Aoki, K., et al. Rapid diagnosis of adenoviral conjunctivitis by PCR and restriction fragment length polymorphism analysis. J. Clin. Microbiol. 34:2113-2116, 1996.
21. Notivol, R., Martinez, M., and Bergamini, M.V. Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Pranoprofen Study Group. Am. J Ophthalmol. 117:651-656, 1994.
22. Belec, L., Tevi-Benissan, C., Bianchi, A., et al. In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. J. Antimicrob. Chemother. 46: 685-693, 2000.
23. Valot, S., Edert, D., and Le Faou, A. A simple method for the in vitro study of the virucidal activity of disinfectants. J. Virol. Methods 86:21-24, 2000.
24. Marcinkiewicz, J., Nowak, B., Grabowska, A., et al. Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperoxidase-halide system. Immunology 98:371-378, 1999.
25. Park, E., Jia, J., Quinn, M.R., et al. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin. Immunol. 102:179-184, 2002.